New pill packaging aims to curb opioid overprescribing after surgery
NCT ID NCT04598074
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a special child-resistant blister pack with clear labeling can help reduce how many opioid pills are prescribed and used after orthopedic surgery. About 352 adults will receive either the new packaging or the standard orange bottle. Researchers will track the number of pills prescribed and used, and see if the new pack improves safety and reduces leftover medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Opioid Package Prototype (special blister pack)
What this could lead to
If it works, this could lead to safer opioid use after surgery by reducing the number of pills prescribed and leftover pills at home.
What could go wrong
This is an early feasibility study, not a large-scale trial. The packaging may not change prescribing habits or patient use as hoped, and results may not apply to other settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UConn Health
Farmington, Connecticut, 06030, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact